Evidence map›Paper›PMID 40698088›Full record

ArticleFrontiers in immunology2025

Complement and coagulation cascade cross-talk in endometriosis and the potential of Janus Kinase inhibitors-a network meta-analysis.

Monika Golinska, Aleksander Rycerz, Matylda Sobczak, Jedrzej Chrzanowski, Konrad Stawiski, Wojciech Fendler

Abstract readNetwork Meta-Analysis
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Monika GolinskaDepartment of Biostatistics and Translational Medicine, Medical University of Lodz, Lodz, Poland.
Aleksander RycerzDepartment of Biostatistics and Translational Medicine, Medical University of Lodz, Lodz, Poland.
Matylda SobczakDepartment of Biostatistics and Translational Medicine, Medical University of Lodz, Lodz, Poland.
Jedrzej ChrzanowskiDepartment of Biostatistics and Translational Medicine, Medical University of Lodz, Lodz, Poland.
Konrad StawiskiDepartment of Biostatistics and Translational Medicine, Medical University of Lodz, Lodz, Poland.
Wojciech FendlerDepartment of Biostatistics and Translational Medicine, Medical University of Lodz, Lodz, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Molecular events that drive endometriosis (EM) and cause accompanying immune deregulation remain elusive. Our purpose was to identify key pathways involved in lesion formation across diverse populations and to detect transcriptomic changes in eutopic endometrium that accompany EM. Methods: We searched Gene Expression Omnibus and ArrayExpress and performed differential gene expression analysis and a network meta-analysis on nine qualifying datasets. Those contained transcriptomic data on 114 ectopic endometrium samples (EL), 138 eutopic endometrium samples from women with endometriosis (EEM), and 79 eutopic endometrium samples from women without endometriosis (EH). Gene ontology and enrichment analysis were performed in DAVID, Metascape, and Cytoscape, and drug repurposing was done in CMap. Results: EEM compared to EH upregulated Conclusion: Our results suggest an interplay between complement and coagulation, mast cells, extracellular matrix remodeling, and the JAK/STAT3 pathway in endometriosis. We underscore the significance of complement C3 and propose JAK inhibitors as therapy candidates. Detected expression differences between EEM and EH are important for the development of diagnosis via endometrial biopsy.

Indexed as

Blood CoagulationComplement System ProteinsEndometriosisJanus Kinase InhibitorsEndometriumFemaleGene Expression ProfilingGene Regulatory NetworksHumansSignal TransductionTranscriptomeComplement System ProteinsJanus Kinase Inhibitorscomplement and coagulationendometriosiseutopic and ectopic endometriumJanus kinase (JAK) inhibitorsmast cellsnetwork meta-analysis

Identifiers

PMID40698088
PMCPMC12279843

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.